AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (699.3 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Application of Rotatable Central Composite Design in the Preparation and Optimization of Poly (Lactic-co-Glycolic Acid) Nanoparticles for Controlled Delivery of HAS

Hua Song1( )Xiufeng Cao2Jing Ruan1Xia Peng3Juan Wang3Can Wang4Chenchen Bao1
Department of Bio-Nano Science and Engineering, National Key Laboratory of Nano/Micro Fabrication Technology, Key Laboratory for Thin Film and Microfabrication of Ministry of Education, Institute of Micro-Nano Science and Technology, Shanghai Jiao Tong University, Shanghai 200240, People’s Republic of China
Department of Physics and Institute of Theoretical Physics and Astrophysics, Xiamen University, Xiamen 361005, China
Department of Laboratory Medicine, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, People’s Republic of China
Xiangya School of Medicine, Central South University, Changsha 410012, People’s Republic of China
Show Author Information

Abstract

The purpose of this work was to obtain an optimized Human Serum Albumin (HSA)-loaded poly(lactic-co-glycolic acid)(PLGA) nanoparticles (NPs). A rotatable central composite design (RCCD) was applied to evaluate the joint influence of three formulation variables: the duration time of homogenization, agitation speed of homogenization, and volume ratio of organic solvent phase to external aqueous phase. The experimental datum allowed the development quadratic models (P<0.05) describing the inter-relationship between the dependent and independent variables. To enhance the protein content and minimize the particle size of the NPs simultaneously, a response surface methodology was employed. By solving the regression equation, and analyzing the response surface contour and plots, the optimal conditions for the preparation of HSA-loaded NPs were found to be: the duration time of homogenization was 4 min, the agitation speed of homogenization was 3.5 krpm and the volume ratio of organic solvent phase to external aqueous phase was 0.6. The entrapment efficiency (E.E.) was 54.52±5.86% and the average particle size is 252.7±17.90 nm. The NPs, as examined by scanning electron microscopy (SEM), have a smooth and spherical surface and particle sizes are less than 500 nm. The results indicated that RCCD represents an ideal and potential technique for NPs preparation optimization.

References

1

Liu C. Research and development of nanopharmaceuticals in China. Nano Biomed. Eng. 2009,1(1):1-12. doi:10.5101/nbe.v1i1.p1-12

2

Agyei D, Danquah MK. Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol. Adv. 2011,29 (3):272-277. doi:10.1016/j.biotechadv.2011.01.001

3

Andrade F, Videira M, Ferreira D, et al. Nanocarriers for pulmonary administration of peptides and therapeutic proteins. Nanomedicine. 2011,6(1):123-141. doi:10.2217/nnm.10.143

4

Liao X, Wang J, Zhang H. Preparation Poly (lactide-co-glycolide) Microsphere of Bone Sialoprotein. Nano Biomed. Eng. 2010,2(2):133-137. doi: 10.5101/nbe.v2i2.

5

Kirby G, White L, Rahman C, et al. PLGA-based microparticles for the sustained release of BMP-2. Polymers. 2011. doi:10.3390/polym3010571

6

Tian F, Prina-Mello A, Estrada G, et al. Macrophage cellular adaptation, localization and imaging of different size polystyrene particles. Nano Biomed. Eng. 2009,1(1):13. doi: 10.5101/nbe.v1i1.p13-26

7

Bajic D, Jozic S, Podrug S. Design of Experiment¡¯s Application in the Optimization of Milling Process. Metalurgija. 2010,49(2):123-126.

8

Rastogi A, Luo Z, Wu Z, et al. Development and characterization of a scalable microperforated device capable of long-term zero order drug release. Biomedical microdevices. 2010:1-7. doi:10.1007/s10544-010-9446-x

9

Brandl F, Kastner F, Gschwind RM, et al. Hydrogel-based drug delivery systems: Comparison of drug diffusivity and release kinetics. Journal of Controlled Release. 2010,142(2):221-228. doi:10.1016/j.jconrel.2009.10.030

10

Elzoghby AO, El-Fotoh WSA, Elgindy NA. Casein-based formulations as promising controlled release drug delivery systems. Journal of Controlled Release. 2011. doi:10.1016/j.jconrel.2011.02.010

11

Li C, Cheng L, Zhang Y, et al. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants. International journal of pharmaceutics. 2010,386(1-2):23-29.

12

Mohammadi G, Barzegar-Jalali M, Valizadeh H, et al. Reciprocal Powered Time model for Release Kinetic Analysis of Ibuprofen Solid Dispersions in Oleaster Powder, Microcrystalline Cellulose and Crospovidone. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Soci t canadienne des sciences pharmaceutiques. 2010,13(2):152.

13

Song H, Chen J M, Liang H J, et al. Optimized preparation of Docetaxel Polysorbate 80/Phospholipid Mixed Micelles Injection by Uniform Design. Chinese Pharmaceutical journal. 2008,43(17):1327-1332.

14

Chen F, Huang P, Mo X. Electrospinning of Heparin Encapsulated P (LLA-CL) Core/Shell Nanofibers. Nano Biomed. Eng. 2010,2(1):84.

15

Anton E, Swetha K, Thomas W, et al. Dextran-based Nanocarriers as Efficient Media Delivery Vehicles to Cell Production Bioreactors. Nano Biomed. Eng. 2010,2(2):126.

16

Chen Y, Chen Y, Chen W, et al. Evolution of phase morphology of high impact polypropylene particles upon thermal treatment. European Polymer Journal. 2007,43(7):2999-3008. doi:10.1016/j.eurpolymj.2007.04.026

17

Zhang K, Wang Y, Hillmyer MA, et al. Processing and properties of porous poly(-lactide)/bioactive glass composites. Biomaterials. 2004,25(13):2489-2500. doi:10.1016/j.biomaterials.2003.09.033

18

Song H, He R, Wang K, et al. Anti-HIF-1 alpha antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials. 2010,31(8):2302-2312. doi:10.1016/j.biomaterials.2009.11.067

19

Song H LB, Du T,Jiang L,Yang H, He R,Gao F, Cui DX. Preparation and characterization of PTX-HIF-1-immunomicelles with active carboxylic terminals. IEEE-NANOMED. 2008:ID:35.

20

Barzegar-Jalali M. Kinetic analysis of drug release from nanoparticles. Journal of Pharmacy & Pharmaceutical Sciences. 2008,11(1):167-177.

21
Krupa I, Nedelcev T, Chorvat D. Glucose diffusivity and porosity in silica hydrogel based on organofunctional silanes. European Polymer Journal. 2011: Article in Press. doi: 10.1016/j.eurpolymj.2011.02.011
Nano Biomedicine and Engineering
Pages 34-41
Cite this article:
Song H, Cao X, Ruan J, et al. Application of Rotatable Central Composite Design in the Preparation and Optimization of Poly (Lactic-co-Glycolic Acid) Nanoparticles for Controlled Delivery of HAS. Nano Biomedicine and Engineering, 2011, 3(1): 34-41. https://doi.org/10.5101/nbe.v3i1.p34-41

374

Views

9

Downloads

6

Crossref

10

Scopus

Altmetrics

Published: 31 March 2011
© 2011 H. Song, et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return